Inmolecule Nanotech, S.A.
MLINA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- ES0105908000
- LEI:
- 959800F0D3TQYVTXW034
- Country:
- Spain
- Address:
- N/A
- Website:
- https://www.inmolecule.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inmolecule Nanotech, S.A. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Inmolecule Nanotech, S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inmolecule Nanotech, S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Provides intravital microscopy systems & CRO services for preclinical research and drug discovery.
South Korea
460470
South Korea
460470
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom
IXI
United Kingdom
IXI
Clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America
JBIO
United States of America
JBIO
Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.
United States of America
JSPR
United States of America
JSPR
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia
JML
Estonia
JML
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel
KDST
Israel
KDST
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea
284620
South Korea
284620
Develops novel oncology therapies to reverse drug resistance and immune suppression.
United States of America
KAPA
United States of America
KAPA
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden
KAN
Sweden
KAN
Oncology-focused drug development firm advancing anti-cancer candidates for brain cancers in trials.
United States of America
KZIA
United States of America
KZIA